News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
85,793 Results
Type
Article (2919)
Company Profile (6)
Press Release (82866)
Multimedia
Podcasts (5)
Webinars (6)
Section
Business (29603)
Career Advice (163)
Deals (5558)
Drug Delivery (24)
Drug Development (7022)
Employer Resources (14)
FDA (1615)
Job Trends (1868)
News (40878)
Policy (4516)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (162)
Accelerated approval (4)
ADA (1)
Allergies (18)
Alliances (5588)
ALS (15)
Alzheimer's disease (192)
Antibody-drug conjugate (ADC) (47)
Approvals (1712)
Artificial intelligence (181)
ASCO (28)
Autoimmune disease (35)
Automation (12)
Bankruptcy (57)
Belgium (10)
Best Places to Work (1406)
BIO (11)
Biologics (10)
BIOSECURE Act (3)
Biosimilars (44)
BioSpace Insights (26)
Biotechnology (17)
Bispecific (1)
Bladder cancer (40)
Brain cancer (10)
Breast cancer (158)
Cancer (806)
Cardiovascular disease (39)
Career advice (141)
Career pathing (5)
CAR-T (8)
CDC (3)
CDMO (24)
Cell-line development (1)
Cell therapy (77)
Cervical cancer (9)
Clinical research (6472)
Collaboration (333)
Commercialization (7)
Company closure (3)
Compensation (34)
Complete response letters (11)
COVID-19 (349)
CRISPR (4)
C-suite (232)
Cystic fibrosis (18)
Data (1009)
Denatured (4)
Depression (21)
Dermatology (15)
Diabetes (60)
Diagnostics (1016)
Digital health (19)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (56)
Drug pricing (14)
Drug shortages (2)
Duchenne muscular dystrophy (29)
Earnings (11171)
Editorial (2)
Employer resources (13)
ESMO (40)
Events (9686)
Executive appointments (232)
Eye disease (2)
FDA (2179)
Fragile X (3)
Funding (228)
Gene editing (19)
Generative AI (8)
Gene therapy (89)
GLP-1 (97)
Government (451)
Grass and pollen (2)
Guidances (112)
Healthcare (2149)
Hematology (12)
HIV (6)
Huntington's disease (7)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (2)
Immunology and inflammation (11)
Immuno-oncology (13)
Indications (28)
Infectious disease (376)
Inflammatory bowel disease (16)
Inflation Reduction Act (3)
Influenza (8)
Intellectual property (37)
Interviews (23)
IPO (2637)
IRA (3)
Job creations (469)
Job search strategy (112)
JPM (6)
Kidney cancer (1)
Kidney disease (17)
Labor market (13)
Layoffs (69)
Leadership (9)
Legal (1220)
Licensing (5)
Liver cancer (7)
Longevity (6)
Lung cancer (112)
Lung diease (3)
Lymphoma (34)
Machine learning (10)
Management (9)
Manufacturing (254)
Marketing (5)
MASH (12)
Medical device (2016)
Medtech (2063)
Mergers & acquisitions (3274)
Metabolic disorders (120)
mRNA (16)
Multiple sclerosis (31)
Netherlands (3)
Neurodegenerative disease (35)
Neuropsychiatric disorders (7)
Neuroscience (354)
NextGen: Class of 2026 (797)
Non-profit (269)
Now hiring (19)
Obesity (44)
Opinion (54)
Ovarian cancer (24)
Pain (36)
Pancreatic cancer (35)
Parkinson's disease (23)
Partnered (21)
Patents (79)
Patient recruitment (65)
Patient selection (7)
Peanut (2)
People (8979)
Peptides (4)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase 1 (1697)
Phase 2 (2999)
Phase 3 (2302)
Pipeline (1719)
Policy (20)
Postmarket research (200)
Preclinical (688)
Press Release (12)
Prostate cancer (34)
Psychedelics (5)
Radiopharmaceuticals (56)
Rare diseases (132)
Real estate (673)
Recruiting (4)
Regenerative medicine (4)
Regulatory (3723)
Reports (25)
Research institute (181)
Resumes & cover letters (24)
Rett syndrome (13)
RNA editing (3)
RSV (5)
Schizophrenia (28)
Series A (22)
Series B (13)
Service/supplier (2)
Sickle cell disease (4)
Spinal muscular atrophy (19)
Sponsored (16)
Startups (351)
State (1)
Stem cells (1)
Stomach cancer (1)
Supply chain (22)
Tariffs (7)
The Weekly (1)
Vaccines (129)
Venture capital (10)
Weight loss (13)
Wet AMD (3)
Women's health (23)
Worklife (3)
Date
Last 7 days (88)
Last 30 days (321)
Last 365 days (4244)
2026 (3570)
2025 (4137)
2024 (4719)
2023 (5161)
2022 (6221)
2021 (7171)
2020 (6524)
2019 (5527)
2018 (4185)
2017 (3671)
2016 (3340)
2015 (3930)
2014 (3042)
2013 (2618)
2012 (2875)
2011 (2860)
2010 (2742)
Location
Africa (96)
Alabama (10)
Alaska (1)
Arizona (45)
Arkansas (1)
Asia (4314)
Australia (563)
California (1612)
Canada (1645)
China (188)
Colorado (93)
Connecticut (30)
Delaware (42)
Europe (8616)
Florida (376)
Georgia (83)
Idaho (9)
Illinois (171)
India (25)
Indiana (165)
Iowa (5)
Japan (76)
Kansas (14)
Kentucky (12)
Louisiana (8)
Maine (8)
Maryland (168)
Massachusetts (934)
Michigan (91)
Minnesota (144)
Missouri (13)
Montana (10)
Nebraska (4)
Nevada (25)
New Hampshire (19)
New Jersey (692)
New Mexico (14)
New York (551)
North Carolina (273)
North Dakota (3)
Northern California (755)
Ohio (72)
Oklahoma (6)
Oregon (3)
Pennsylvania (376)
Puerto Rico (11)
Rhode Island (3)
South America (143)
South Carolina (12)
Southern California (655)
Tennessee (42)
Texas (483)
United States (6636)
Utah (25)
Virginia (38)
Washington D.C. (8)
Washington State (110)
Wisconsin (56)
Wyoming (4)
85,793 Results for "sharps compliance corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sharp Therapeutics Corp. Reports First Half 2026 Results and Development Update
August 28, 2026
·
3 min read
Press Releases
Sharp Therapeutics Corp. Announces Results from Annual Meeting of Shareholders
July 21, 2026
·
3 min read
Press Releases
Sharp Therapeutics Announces Closing of Non-Brokered Private Placement
July 29, 2026
·
4 min read
Press Releases
Sharp Therapeutics Corp. Announces Fourth Quarter 2025 Results, Closing of Convertible Note Offering and Adoption of Semi-Annual Reporting
April 20, 2026
·
7 min read
Press Releases
Sharp Therapeutics Announces Non-Brokered Private Placement and Provides Operational Update
July 15, 2026
·
4 min read
Press Releases
Sharp Therapeutics Corp. Reports Third Quarter 2025 Results and Development Update
November 26, 2025
·
3 min read
Press Releases
Sharp Biomedical Closes Pre-Seed Funding Led by Gener8tor to Advance Outpatient Spine Procedures for Early-to-Mid-Stage Chronic Pain
October 12, 2026
·
3 min read
Press Releases
Sharp Therapeutics Announces Filing of Amended and Restated Management Information Circular and New Annual Meeting Date
Shareholders Must Recast Their Votes to be Counted
June 30, 2026
·
4 min read
Press Releases
Anavex Life Sciences Regains Compliance with Nasdaq Periodic Filing Requirement
September 2, 2026
·
3 min read
Press Releases
NEXGEL Regains Compliance with Nasdaq Listing Requirement - October 27, 2026
October 27, 2026
·
3 min read
1 of 8,580
Next
